Cannabis Deserves Evidence-Based Medicine. We're Building It.
From clinical trials to patient outcomes, Hytiva leads cannabis research that empowers physicians, advances pharmaceuticals, and informs the patients who rely on cannabis for their health.
Closing the Gap Between Cannabis and Clinical Evidence
Cannabis is one of the most widely used therapeutic substances in the world, yet clinical evidence still lags behind patient demand. We bridge this gap by conducting original research that provides physicians the data to prescribe with confidence, pharma teams the evidence to develop targeted treatments, and patients the science to make informed decisions about their care.
What We Study
Our research covers the clinical, pharmacological, and public health questions that matter to medical cannabis.
-
Medical
Clinical Therapeutics
Investigating the efficacy of cannabinoids for chronic pain, epilepsy, anxiety, and neurological conditions through controlled clinical trials.
-
Safety
Safety, Dosing & Drug Interactions
Establishing precise dosing protocols, identifying drug-drug interactions, and developing the safety profiles critical for clinical practice.
-
Science
Cannabinoid Pharmacology
Unlocking the molecular mechanisms of cannabinoids, terpenes, and the entourage effect to drive innovation in pharmaceutical development and patient outcomes.
Collaborate With Us
We partner with pharmaceutical companies, universities, hospitals, and research institutions to accelerate the future of medical cannabis. Whether you're launching a clinical trial or exploring a novel therapeutic application, our team provides the expertise and infrastructure to move your research forward.
Start a Conversation